1. Home
  2. TENX vs EMKR Comparison

TENX vs EMKR Comparison

Compare TENX & EMKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • EMKR
  • Stock Information
  • Founded
  • TENX 1967
  • EMKR 1984
  • Country
  • TENX United States
  • EMKR United States
  • Employees
  • TENX N/A
  • EMKR N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • EMKR Semiconductors
  • Sector
  • TENX Health Care
  • EMKR Technology
  • Exchange
  • TENX Nasdaq
  • EMKR Nasdaq
  • Market Cap
  • TENX 11.4M
  • EMKR 9.5M
  • IPO Year
  • TENX N/A
  • EMKR 1997
  • Fundamental
  • Price
  • TENX $4.94
  • EMKR $2.94
  • Analyst Decision
  • TENX Strong Buy
  • EMKR Buy
  • Analyst Count
  • TENX 4
  • EMKR 2
  • Target Price
  • TENX $20.67
  • EMKR $3.00
  • AVG Volume (30 Days)
  • TENX 96.4K
  • EMKR 508.4K
  • Earning Date
  • TENX 11-13-2024
  • EMKR 12-10-2024
  • Dividend Yield
  • TENX N/A
  • EMKR N/A
  • EPS Growth
  • TENX N/A
  • EMKR N/A
  • EPS
  • TENX N/A
  • EMKR N/A
  • Revenue
  • TENX N/A
  • EMKR $90,961,000.00
  • Revenue This Year
  • TENX N/A
  • EMKR N/A
  • Revenue Next Year
  • TENX N/A
  • EMKR $7.07
  • P/E Ratio
  • TENX N/A
  • EMKR N/A
  • Revenue Growth
  • TENX N/A
  • EMKR 413.79
  • 52 Week Low
  • TENX $2.77
  • EMKR $0.78
  • 52 Week High
  • TENX $41.92
  • EMKR $7.20
  • Technical
  • Relative Strength Index (RSI)
  • TENX 64.74
  • EMKR 73.62
  • Support Level
  • TENX $4.50
  • EMKR $2.90
  • Resistance Level
  • TENX $5.09
  • EMKR $3.06
  • Average True Range (ATR)
  • TENX 0.27
  • EMKR 0.10
  • MACD
  • TENX 0.01
  • EMKR 0.06
  • Stochastic Oscillator
  • TENX 81.01
  • EMKR 90.00

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About EMKR EMCORE Corporation

EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.

Share on Social Networks: